TGFB1 and neoplasm: Each T‐cell mixture was challenged with two rounds of cognate tumor cells (i.e., NY‐ESO‐1+ M407 melanoma or CD20+ Raji, neither of which shows changes in growth rate in response to TGF‐β alone) (Figure 1a,b).